First reported allergen immunotherapy anaphylaxis treated with neffy nasal spray: A case series
The neffy intranasal epinephrine delivery system was recently approved by the US Food and Drug Administration; however, published information on its real-world use is limited. Immunotherapy patients reacting in our clinic experienced prompt symptom resolution with neffy, highlighting its viability a...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2025-11-01
|
| Серія: | Journal of Allergy and Clinical Immunology: Global |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2772829325001651 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|